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Abstract 16 
The burden of noncommunicable diseases (NCD) on health systems worldwide is 17 
substantial. Physical inactivity and sedentary behaviour are major risk factors for NCD. 18 
Previous attempts to understand the value for money of preventative interventions targeting 19 
physically inactive individuals have proved to be challenging due to key methodological 20 
challenges associated with the conduct of economic evaluations in public health. A 21 
systematic review was carried out across six databases (Medline, SPORTSDiscus, EconLit, 22 
PsychINFO, NHS EED, HTA) along with supplementary searches. The review examines 23 
how economic evaluations published between 2009-March 2017 have addressed 24 
methodological challenges with the aim of bringing to light examples of good practice for 25 
future studies. Fifteen economic evaluations from four high-income countries were retrieved; 26 
there is a dearth of studies targeting sedentary behaviour as an independent risk factor from 27 
physical activity. Comparability of studies from the healthcare and societal perspectives 28 
were limited due to analysts’ choice in cost categories, valuation technique and time horizon 29 
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differing substantially. The scarcity of and inconsistencies across economic evaluations for 30 
these two behaviours have exposed a mismatch between calls for more preventative action 31 
to tackle NCD and the lack of information available on how resources may be optimally 32 
allocated in practice. Consequently, this paper offers a table of recommendations on how 33 
future studies can be improved.  34 
 35 
Keywords 36 
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Public Health; Cost effectiveness analysis; Cost utility analysis  38 
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Introduction 39 
Background 40 
The burden of noncommunicable disease (NCD) on health systems is substantial. 41 
Worldwide NCD is the main cause of death and disability (WHO, 2018a). Physical inactivity 42 
is a major risk factor for NCD and the fourth leading cause of death globally. There is 43 
therefore an urgent need to invest in preventative interventions, such as those targeting 44 
individuals who do not meet the international guidelines of 150 minutes of moderate physical 45 
activity per week (Kohl et al., 2012). Furthermore, sedentary behaviour, defined as any 46 
waking behaviour where an individual is in a sitting, reclining or lying posture, has been 47 
identified as a risk factor for NCD and all-cause mortality independent of achieving the 48 
recommended physical activity guidelines. The level of physical activity found to attenuate 49 
the risks associated with sedentary behaviour is 60 minutes of moderate physical activity per 50 
day, which equates to 420 minutes per week (Ekelund et al., 2016). As over a third (35%) of 51 
females and a quarter (26%) of males in high-income countries do not presently meet the 52 
recommended weekly guidelines, a daily target of 60 minutes is unlikely to be attained 53 
(WHO, 2018b). Inaction to invest in preventative interventions tackling detrimental levels of 54 
physical inactivity and sedentary behaviour is expected to lead to greater levels of NCD and 55 
inequity, productivity losses and a continued overwhelming demand for costly curative health 56 
services (OECD, 2015). 57 
As public resources are scarce, economic evaluations are important to prevent both national 58 
and local policymakers from disinvesting in highly cost-effective physical activity and 59 
sedentary behaviour interventions. Economic evaluations are also needed as not all public 60 
health interventions represent good value for money (Owen et al., 2017). Compared to 61 
population-level interventions, physical activity and sedentary behaviour interventions 62 
targeting individuals who are not meeting the recommended international physical activity 63 
guidelines are more likely to be: (a) funded by local-level commissioners; (b) evaluated by 64 
researchers. This is likely to be due to the challenge of measuring outcomes in the general 65 
population. For this reason, this review focuses on economic evaluations of targeted 66 
4 
 
interventions such as exercise referral schemes, brief advice in primary care and exercise 67 
sessions. 68 
Despite recommendations for economic evaluations to become routine within public health 69 
interventions (Kelly et al., 2005) cost-effectiveness information on physical activity and 70 
sedentary behaviour interventions remains scarce (Abu-Omar et al., 2017). One reason for 71 
this lack of analysis may be due to the lack of guidance and multidisciplinary efforts to inform 72 
analysts on how to conduct economic evaluations in the field of public health (Davis et al., 73 
2014). Economic evaluations of public health interventions are subject to four key 74 
methodological challenges identified and described in former reviews (Alayli-Goebbels et al., 75 
2014; Hill et al., 2017; Weatherly et al., 2009) as: attribution of effects; measuring and 76 
valuing outcomes; identifying intersectoral costs and consequences; and incorporating 77 
equity. These four challenges are explain in the subsequent sections. 78 
Challenge 1: Attribution of effects 79 
Randomised controlled trials (RCTs) are the gold standard for evaluating the effectiveness 80 
of an intervention. RCTs alone are however insufficient to inform long-term investment 81 
decisions in health systems aiming to be sustainable. This is because conducting 82 
experimental studies such as RCTs over many years or decades is likely to be resource 83 
intensive from both the research funder and participant’s perspective. Attrition from the trial 84 
and insufficient funding is inevitable. Yet, the greatest health outcomes and cost savings 85 
attributable to physical activity and sedentary behaviour interventions do not typically 86 
manifest until decades after an intervention has taken place.  Due to this long pay-back time 87 
(Wanless, 2004), it is recommended economic evaluations link up trial-derived intermediate 88 
or surrogate outcomes with additional sources of evidence (e.g. observational studies) 89 
(Ramsey et al., 2015). 90 
Challenge 2: Measuring and valuing outcomes  91 
Previous physical activity studies have used different outcomes, or have classified the same 92 
type of outcomes in different ways, which makes it challenging to meaningfully use cost-93 
effectiveness results and compare interventions (Abu-Omar et al., 2017). This is likely to be 94 
because physical activity and sedentary behaviour interventions are associated with a broad 95 
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range of outcomes, many of which are not captured in evaluations that conduct just one type 96 
of valuation analysis. Furthermore, many broader important and relevant outcomes such as 97 
improved wellbeing or someone’s ability to return to work are difficult to assign a monetary 98 
value, as they do not have a market price (Weatherly et al., 2014).  99 
 100 
Challenge 3: Identifying intersectoral costs and consequences 101 
Many physical activity and sedentary behaviour interventions take place outside of the 102 
healthcare setting, necessitating a time and equipment commitment from intervention 103 
participants and providers (which has an opportunity cost). Moreover, physical activity and 104 
sedentary behaviour interventions are complex, impacting on various sectors simultaneously 105 
(Dahlgren & Whitehead, 1991). Therefore, it is important to consider the impact of these 106 
interventions on other stakeholders including public sector agencies beyond the health 107 
sector, private individuals and the voluntary sector (Weatherly et al., 2014; Weatherly et al., 108 
2009). Yet, as there is no universal definition for each perspective type, the costs and 109 
consequences deemed relevant for inclusion in the analysis is primarily analyst-dependent 110 
(Husereau et al., 2013). 111 
Challenge 4: Incorporating equity  112 
A key objective in public health is to reduce inequity, meaning inequalities that are 113 
avoidable, but have not yet been avoided and are therefore unfair (Marmot & Allen, 2014). 114 
By contrast, a key objective in economic evaluation is to maximise efficiency across the 115 
whole population (Weatherly et al., 2014). If authors fail to acknowledge equity by not 116 
adapting their existing economic analysis approach, it is not transparent which socio-117 
economic group have gained or lost out due to a resource allocation decision. Until the 118 
recent publication by Cookson et al. (Cookson et al., 2017) recommendations on how to 119 
incorporate equity have been limited within international and national guidelines for 120 
economic evaluation (Husereau et al., 2013; NICE, 2014; Ramsey et al., 2015; Sanders et 121 
al., 2016). Approaches for incorporating equity into the analysis described by Cookson et al. 122 
(2017) include: equity impact analysis, equity constraint analysis and equity weighting 123 
analysis. 124 
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 125 
Aim 126 
In an attempt to learn how the four challenges outlined above have been addressed in 127 
practice, this systematic review aims to provide an overview of the methods used in 128 
economic evaluations of physical activity and sedentary behaviour interventions since 2009. 129 
Alayli-Goebbels et al. (2014) and Weatherly et al. (2009) reviewed the methods reported in 130 
economic evaluations of a range of public health areas including 17 and 26 physical activity 131 
economic evaluations published up to 2005 and 2009, respectively, but the reviews found 132 
little insight from the empirical evidence. Economic evaluation is a rapidly developing field 133 
especially with the growth of decision-analytic modelling and the economic evaluation 134 
reporting standards (Drummond et al., 2015; Ramsey et al., 2015). Accordingly there is a 135 
strong rationale to provide an update on methods carried out since 2009.  136 
 137 
Methods 138 
Information sources and search strategy 139 
A comprehensive search took place across six electronic databases that host reports from 140 
the medical and economic field (Medline via Ovid; SPORTSDiscus, EconLit and PsycINFO 141 
via EBSCOHost; NHS EED and HTA via the Cochrane Library). The database NHS EED 142 
stores records up to April 2015, thus searches in this database went up to 2015 only. 143 
Additional, supplementary searching was performed: key websites were searched for 144 
studies that included specific free text terms: ‘physical activity’, ‘sedentary behaviour’, 145 
‘economic’ and ‘cost’; reference lists of two relevant systematic reviews (Gc et al., 2016; Wu 146 
et al., 2011) were hand searched; and protocols that met the majority of the eligibility criteria 147 
were used to search for completed studies via online searching and contacting the authors. 148 
An example of the full electronic search strategy for Medline is provided in Appendix A 149 
[INSERT LINK TO ONLINE FILE A, B, C, D & E]. This search was replicated for all databases, 150 
with amendments made as appropriate to align terms with individual database index terms.  151 
Study selection 152 
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The protocol for this review can be retrieved from the PROSPERO database for registered 153 
systematic reviews (registration number CRD42017074382). Full economic evaluations of 154 
interventions targeting individuals aged 16 years or over, who are defined as being 155 
physically inactive or sedentary, were eligible for inclusion in the review. Population level 156 
interventions were excluded as well as protocols. Eligible studies needed to capture physical 157 
activity or sedentary behaviour at two or more time points to observe if a change in 158 
behaviour has occurred. Comparators could be any alternative intervention including no 159 
intervention. Interventions and comparators targeting multiple behaviours such as physical 160 
activity and diet were excluded unless the multiple behaviours were physical activity and 161 
sedentary behaviour. Both trial and model based economic evaluations were eligible. Letters 162 
to editors and conference briefings were excluded. Both published and unpublished ‘grey’ 163 
literature were included. Abstracts where the full text could not be retrieved were excluded. 164 
Only English language studies were included due to the restricted language skills of the 165 
reviewers available. Eligibility criteria was applied during both screening phases. The 166 
present systematic review identifies and discusses studies published from January 2009 to 167 
March 2017. In addition, a rapid systematic scoping search was performed in Medline to 168 
understand whether new studies had been published in this area from March 2017 to 169 
January 2019. Details on methods of the scoping search are not discussed below, rather 170 
they are presented in Appendix B [INSERT LINK TO ONLINE FILE A, B, C, D & E]. 171 
Screening 172 
During the title and abstract screening phase two reviewers (first author, seventh author) 173 
screened 10% (n=612/ 6,123) of the studies and there was a disagreement rate of 2.94% 174 
(n=18). Reviewers discussed the disagreements and resolved them without the need to 175 
seek the expertise of a third reviewer. Reviewer one (first author) went on to screen the rest 176 
of the studies, informed by the disagreement discussions. Similarly, during the full text 177 
screening phase reviewer two (seventh author) screened 10% (n=15/ 153) of the studies. 178 
There was disagreement for 33.33% (n=5) of the studies. The reviewers discussed the 179 
disagreements and again a consensus was met without the need for a third reviewer. Figure 180 
1 shows an overview of the study selection process. 181 
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Data extraction 182 
A data extraction form was developed based on the items featured on the Consolidated 183 
Health Economic Evaluation Reporting Standards (CHEERS) checklist (Husereau et al., 184 
2013). The form was piloted independently by two reviewers (first author, seventh author) on 185 
two (10%) randomly selected studies. Following discussions the form was shortened, and 186 
items relevant to the four methodological challenges, and key study characteristics were 187 
retained. Following the piloting stage, the first reviewer extracted data for the remaining 188 
studies. A template of the final data extraction form is provided in Appendix C [INSERT LINK 189 
TO ONLINE FILE A, B, C, D & E]. It was not necessary to request additional information from 190 
the study authors.  191 
Quality assessment 192 
Drummond’s 10-item checklist was selected as it is one of the most widely used quality 193 
assessment tools (Drummond et al., 2015). A component approach was used when applying 194 
the checklist in Appendix D [INSERT LINK TO ONLINE FILE A, B, C, D & E]. This approach is 195 
advocated in the PRISMA statement and entails assessing each item individually rather than 196 
generating a summary score (Liberati et al., 2009). Two reviewers (first author, seventh 197 
author) independently conducted the quality assessment for 10% (n=2/ 15) of the included 198 
studies. Disagreement was limited to item 6 (Item 6: Were costs and consequences valued 199 
credibly?) on the checklist, examples in Drummond et al. (2015) were consulted to 200 
overcome these disagreements. Practical application of item 10 (Item 10: Did the 201 
presentation and discussion of study results include all issues of concern to the users?) was 202 
challenging due to the limited guidance, thus findings from this question are less informative. 203 
Alayli-Goebbels et al. (2014) also experienced this barrier in an earlier version of the 204 
checklist.  205 
Method of analysis 206 
The published narrative synthesis framework by Popay et al. (2006) guided the analysis to 207 
ensure a transparent and systematic approach was performed. The narrative synthesis in 208 
this review goes beyond describing how authors have addressed each of the four challenges 209 
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by attempting to explain why specific approaches have been chosen. The analysis was an 210 
iterative process. A priori analysis involved tabulating the data and producing bar charts on 211 
key study characteristics: study design, time horizon, valuation technique, study perspective 212 
and explicit/ implicit equity analysis. The same study characteristics were focused on in the 213 
two former methodological reviews (Alayli-Goebbels et al., 2014; Weatherly et al., 2009). 214 
The wider literature also indicated that the following contextual factors were important to 215 
review when understanding an analyst’s approach: intervention setting, country and year of 216 
publication. Additional ad hoc analyses were performed where trends became apparent. 217 
Lastly, the strength of the narrative synthesis and the conclusions derived from it were 218 
considered by reflecting on the quantity of studies and results of the quality assessment.  219 
Results 220 
A total of 15 economic evaluations (17 publications) were included in the review (Figure 1). 221 
Searching across Medline, SPORTSDiscus, EconLit, PsychINFO, NHS EED and HTA 222 
databases retrieved 7,063 records. Supplementary searching retrieved six additional records 223 
including: two records from hand searching on key websites, two from the reference list of a 224 
systematic review (Gc et al., 2016), and a further two from searching for the completed 225 
studies of two protocols (de Vries et al., 2013; Kolt et al., 2009) in Appendix E [INSERT LINK 226 
TO ONLINE FILE A, B, C, D & E]. After removing duplicates 6,129 records remained of which a 227 
further 5,907 records were removed as title and abstracts did not meet the eligibility criteria. 228 
During the full text screening, 159 citations were examined in further detail, of which 142 229 
studies were excluded. Reasons are outlined in Figure 1.  230 
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 231 
Figure 1. PRISMA flow diagram representing study selection process 232 
Study characteristics 233 
Of the 15 studies, ten were single trial-based economic evaluations and five were model-234 
based; no studies were single trials that had extrapolated or modelled their results. Table 1 235 
provides an overview of study characteristics for the trial- and model-based studies 236 
respectively. Studies are arranged by country followed by year of publication. Interventions 237 
were set in primary care, community and the home, and setting did not appear to be related 238 
to intervention type or country. As shown in Table 1, no studies targeted sedentary 239 
behaviour as an independent risk factor from physical activity. The range of interventions 240 
was limited to the following types: physical activity programme/ on prescription in primary 241 
care (n=9); brief advice in primary care (n=2); home-based informational advice (n=1); 242 
physical therapy in a physical therapy setting (n=1); and fall prevention programme in both 243 
primary care and the home (n=1). The remaining study compared strategies for recruiting to 244 
physical activity interventions in primary care. The overall range of adult-based interventions 245 
matches the narrow range identified in a recent review of reviews focussing on the economic 246 
results of physical activity interventions (Abu-Omar et al., 2017). Studies came from four 247 
11 
 
high-income countries. More than half (n=8) of the 15 studies came from the UK, with the 248 
remaining coming from New Zealand (n=3), the USA (n=2), and the Netherlands (n=2) 249 
(Table 1).  250 
Quality assessment 251 
Overall, studies performed well against Drummond’s 10-item quality assessment checklist 252 
(Drummond et al., 2015) in Appendix D [INSERT LINK TO ONLINE FILE A, B, C, D & E]. 253 
Nevertheless, six studies scored ‘No’ on at least one item: two studies did not state their 254 
perspective (item 1); three studies did not include all costs and consequences relevant to their 255 
stated perspective (item 4); one study did not discount its costs and consequences (item 7); 256 
and one study did not report their price source (item 6). Interpretation on whether item 4 was 257 
met by any of the ten trial-based economic evaluations who captured costs and outcomes at 258 
two years or less, is up for debate. It could be argued that not all important and relevant costs 259 
and consequences can be identified for studies, which do not take a systems approach (e.g. 260 
if they do not consider the impact on the wider system in which an intervention is being 261 
implemented nor capture the long-term impact) (Rutter et al., 2017; Squires et al., 2016). In 262 
order to align with other reviews which have used Drummond’s checklist, the quality 263 
assessment results for item 4 were based on the checklist’s accompanying guidance 264 
(Drummond et al., 2015). Costs and consequences identified, measured and valued are 265 
discussed in greater depth in the subsequent sections. 266 
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Table 1: Overview of economic evaluations 267 
Trial-based economic evaluations 
Study &  
Year of 
publication 
Stated 
perspective  
Country Population 
targeted 
Sample 
size 
Intervention  Comparator Setting Valuation 
technique 
Iliffe et al. 
2014 
Health 
sector 
UK Inactive ≥65 years 
old who had fallen 
less than times in 
the previous 12 
months 
100 Falls Management 
Exercise Programme 
(Weekly group exercise 
class & 2 home-based 
exercise sessions) 
Usual care (no 
intervention);  
Otago Exercise 
Programme  
Primary 
care & 
community 
(as Home-
based) 
CEA 
Edwards et 
al. 2013;  
Murphy et al. 
2012 
Multi-
agency 
public 
sector  
UK Sedentary, and 
over 16 years, 
with risk factors 
for coronary heart 
disease, or mild to 
moderate anxiety, 
depression or 
stress. 
798 ERS (primary care) Information leaflet 
only 
Primary 
care 
CUA 
Boehler et al. 
2011 
Health 
sector 
UK Inactive adults, 16 
to 74 years old 
46 Opportunistic 
recruitment strategy for 
physical activity 
interventions  
Disease register 
strategy; Hypothetical 
no intervention 
strategy 
Primary 
care 
CEA 
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Shaw et al. 
2011 
Not 
reported 
UK Inactive, adults 
(age not defined) 
79 Individualised walking 
programme: a 
pedometer and a 30-min 
consultation  
Individualised walking 
programme: a 
pedometer, but and 5 
min brief advice 
Primary 
care 
CEA 
Larsen et al. 
2015 
Payer USA Inactive Latina 
women, 18-65 
years old 
266 Home print-based mail-
delivered MVPA 
intervention linguistically 
and culturally adapted 
for Latinas 
Wellness contact 
(information on health 
topics excluding 
MVPA) 
Home-
based 
CEA 
Young et al. 
2012 
Societal  USA Women, following 
coronary artery 
bypass surgery  
40 Symptom management 
intervention delivered by 
telehealth device to 
improve the physical 
activity level  
Usual care, 2 week 
follow up call by the 
primary providers and 
cardiac specialists 
Community CEA 
de Vries et 
al. 2016 
Societal  
 
Netherlands Sedentary adults 
(or at risk of losing 
active lifestyle in 
near future) with 
mobility problems, 
≥70 years old 
130 Patient-centred physical 
therapy  
Usual care for 
physical therapy, less 
patient-centred 
Physical 
therapy 
setting 
CUA 
Maddison et 
al. 2015 
Not 
reported 
New 
Zealand  
≥18 years old with 
diagnosis of IHD 
171 Exercise prescription 
and behavioural support 
Usual care 
(participation in usual 
Cardiac Rehabilitation 
Home-
based 
CEA; CUA 
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within previous 3- 
24 months.  
by mobile phone text 
messages and internet  
e.g. education session 
and psychological 
support) 
Leung et al. 
2012 
Public 
health 
system and 
participant  
New 
Zealand 
Inactive adults, 
≥65 years old 
330 Pedometer-based 
prescription, focus was 
on step-related goals  
Green prescription, 
focus was on physical 
activity time-related 
goals 
Community CEA; CUA 
Elley et al. 
2011 
Societal  New 
Zealand 
Inactive, 40- 74 
years old 
974 Enhanced green 
prescription, 10 min of 
brief advice and a 
written exercise 
prescription with 
telephone support at 9 
months and 30min face-
to-face support at 6 
months  
 
 
 
 
 
 
Usual care from GP 
(not standard green 
prescription, usual 
care from GP not 
defined) 
Primary 
care 
CEA 
15 
 
Model-based economic evaluations 
Study &  
Year of 
publication 
Stated 
perspective  
Country Population 
targeted 
Model type & 
size of 
simulation 
cohort 
Intervention  Comparator Setting Valuation 
technique  
Campbell et 
al. 2015 
Health 
Sector 
UK Sedentary 
adults, ≥50 
years old 
Markov 
model 
(100,000 
simulation 
cohort) 
ERS (primary care) Usual care (refers to 
Pavey et al. 2011’s 
definition) 
Primary care CUA  
Anokye et al. 
2012; 
Anokye et al. 
2014  
Health 
sector; 
Health 
sector and 
participant 
for CCA 
UK Inactive, 
≥33 years 
old 
Markov 
model 
(100,000 
simulation 
cohort) 
Brief Advice (primary 
care) 
Usual care (no  
intervention) 
Primary care CUA (and 
CCA) 
Anokye et 
al., 2011 
Health 
sector  
UK Sedentary 
adults, 40-
60 years old 
Decision tree 
model (1,000 
simulation 
cohort) 
ERS (primary care) Usual care (refers to 
Pavey et al. 2011’s 
definition) 
Primary care CUA 
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Pavey et al. 
2011 
Health 
sector 
CUA; 
Partial-
societal for 
CCA 
UK Sedentary 
adults, 40-
60 years old 
Decision tree 
model (1,000 
simulation 
cohort) 
ERS (leisure centre) Usual care (no 
active ingredient- PA 
advice or leaflets) 
Leisure-
centre  
CUA (and 
CCA) 
Over et al. 
2012 
Health 
sector 
Netherlands Inactive, 20- 
65 year olds 
Markov 
model 
(100,000 
simulation 
cohort) 
GP pedometer 
prescription, counselling 
combined with 
pedometer use 
Usual care (no 
intervention) 
Primary care CUA 
 ERS: Exercise Referral Scheme; GP: General Practitioner; MVPA: Moderate-to-vigorous physical activity; CEA: cost-effectiveness analysis; CUA: Cost-utility 268 
analysis 269 
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Challenge 1: Attribution of effects 270 
Two thirds (n=10) of the studies in this review, all trial-based, did not compare the costs and 271 
consequences of the comparator groups beyond the trial follow up period (Table 3). More 272 
specifically, one study compared costs and consequences over a two-year period (Elley et 273 
al., 2011), the remaining nine had a time horizon of 12-months or less. For six of these 274 
studies, authors referred to their short time horizon as a limitation of their study (Boehler et 275 
al., 2011; de Vries et al., 2016; Edwards et al., 2013; Larsen et al., 2015; Leung et al., 2012; 276 
Shaw et al., 2011). For instance, it precluded the incorporation of any potential long-term 277 
healthcare savings (Larsen et al., 2015). Just one study suggested future modelling 278 
exercises could be used to address this challenge (Edwards et al., 2013). Yet, for Shaw et 279 
al. (Shaw et al., 2011) a short-time horizon was justified as they reported there was 280 
insufficient data to extrapolate their results over the participants’ lifetime.  281 
 282 
By contrast, all five model-based studies extrapolated a pooled trial-derived effectiveness 283 
estimate over the rest of the participants’ lifetime; bridging the gap between the short- and 284 
long-term evidence (Table 2). Nevertheless, the assumptions underpinning the model-based 285 
studies varied considerably. Two studies (Anokye et al., 2011; Pavey et al., 2011) made 286 
large assumptions unsupported by evidence about the duration of the effect, assuming that 287 
any short-term change in physical activity observed in the trials 6-12 months after the 288 
intervention, would be long-lasting. Over et al. (2012) employed a different approach by 289 
extrapolating an effect estimate, observed at 18 weeks, over a 40-year time horizon (the life 290 
expectancy of the participants). The authors assumed that only 25% of the effect recorded at 291 
18 weeks would remain over the 40-year time horizon; they too reported that their 292 
assumptions were unsupported by evidence. These findings demonstrate how studies will 293 
vary according to the assumptions made. It is therefore important that end-users of cost-294 
effectiveness results check they agree with the assumptions that underpin the economic 295 
evaluation. 296 
 297 
Assumptions underlying the two other model-based studies (Anokye et al., 2012; Campbell 298 
et al., 2015) were supported by three robust cohort studies. Campbell et al. (2015) replicated 299 
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Anokye et al.’s (2012) approach. More specifically, they linked the short-term change in 300 
physical activity level observed in trial data, with Hu et al.’s (2007; 2003; 2005) cohort 301 
studies that followed a group of active and inactive individuals for a duration of at least 10 302 
years to predict how their activity levels and risk of disease changed over time. Anokye et al. 303 
(2012) explain how their identification and use of the cohort studies has strengthened 304 
previous modelling attempts in the field of physical activity. Campbell et al.(2015) reported 305 
this approach has enabled more conservative assumptions to be made around changing 306 
physical activity levels and disease development over time. 307 
 308 
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Table 2. Time horizon and types of outcomes compared to costs  309 
Trial-based economic evaluations 
Study &  
Year of publication 
Time Horizon 
(trial follow up) 
Types of outcomes compared to costs per valuation technique 
Larsen et al. 2015 Trial duration 
(12 months) 
CEA: Cost per minute of increase in physical activity 
Iliffe et al. 2014 Trial duration 
(12 months) 
 
CEA: Cost per participant reaching or exceeding 150 minutes of moderate-to-vigorous physical activity per 
week  
Young et al. 2012 Trial duration  
(3 months) 
CEA: Cost per incremental change in daily estimated energy expenditure;  
 
CEA: Cost per the incremental change in minutes spent on moderate-to-vigorous activity 
Elley et al. 2011 Trial duration 
(24 months;   
12 months) 
CEA: Cost per participant achieving 150 minutes of moderate intensity activity per week 
Boehler et al. 
2011 
Trial duration    
(3 months) 
CEA: Cost per participant achieving 150 minutes of moderate intensity activity per week 
Shaw et al. 2011 Trial duration 
(12 months) 
CEA: Cost per additional person achieving the target of a weekly increase of ≥ 15,000 steps. 
Maddison et al. 
2015 
Trial duration 
(24 weeks /      
[6 months]) 
CEA: Cost per MET-hour of walking and leisure activity;  
CUA: Cost per short-term QALY gain 
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Leung et al. 2012 Trial duration 
(12 months) 
CEA: Cost per 30 minutes of weekly leisure walking;  
CUA: Cost per short-term QALY gain 
 
de Vries et al. 
2016 
Trial duration   
(6 months) 
CUA: Cost per short-term QALY gain 
 
Edwards et al. 
2013;  
Murphy et al. 2012 
Trial duration 
(12 months) 
CUA: Cost per short-term QALY gain 
 
Model-based economic evaluations 
Study &  
Year of publication 
Time Horizon 
(trial follow up) 
Types of outcomes compared to costs per valuation technique 
Campbell et al. 
2015 
Lifetime CUA: Cost per short-term QALY gain (mental health gain); Cost per QALYs associated with coronary heart 
disease, stroke, type 2 diabetes due to reduced risk for developing these health states 
Anokye et al. 
2012; Anokye et 
al. 2014  
Lifetime CUA: Cost per short-term QALY gain (mental health gain); Cost per QALYs associated with coronary heart 
disease, stroke, type 2 diabetes due to reduced risk for developing these health states 
CCA: Same outcomes outlined below for Pavey et al.’s (2011) CCA 
Anokye et al., 
2011 
Lifetime CUA: QALYs associated with coronary heart disease, stroke, type 2 diabetes due to reduced risk for 
developing these health states 
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Pavey et al. 2011 Lifetime CUA: Cost per short-term QALY gain (mental health gain); Cost per QALYs associated with coronary heart 
disease, stroke, type 2 diabetes due to reduced risk for developing these health states 
CCA: Mental health (anxiety), Mental health (depression), Metabolic diabetes, Colon cancer, Breast cancer , 
Lung cancer, Hypertension (cardiovascular), Coronary Heart Disease, Stroke, Musculoskeletal (Osteroporosis), 
Musculoskeletal (Osteroarthritis), Lower back pain, Rhumatoid arthritis, Falls prevention, Absenteeism at work, 
Injury (disbenfit), Disability 
Over et al. 2012 Lifetime CUA: QALYs associated with myocardial infarction, stroke, diabetes, colorectal cancer, breast cancer due to 
reduced risk for developing these health states 
 310 
RCT: randomised controlled trial; cRCT: cluster randomised controlled trial; CEA: Cost-effectiveness analysis; CUA: Cost-utility analysis; CCA: cost-311 
consequence analysis ; MET: Metabolic Equivalent of Task 312 
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Challenge 2: Measuring and valuing outcomes 313 
No studies in this present review conducted a cost-benefit analysis (CBA), despite health 314 
economists (Drummond et al., 2015) stating this approach is superior to cost-utility analysis 315 
(CUA) (Drummond et al., 2015). Recent UK and US guidelines recommended that studies 316 
report a broad range of outcomes alongside their economic analyses, through the use of 317 
approaches such as CBA, cost-consequence analysis (CCA) or an impact inventory (NICE, 318 
2014; Sanders et al., 2016). Two studies (Anokye et al., 2012; Pavey et al., 2011) included a 319 
CCA conducted alongside a CUA. A broad range of health outcomes were included in their 320 
CCA (Table 2) yet the only non-health outcome reported was absenteeism. 321 
Two thirds (n=11) of the studies presented just one type of valuation technique, either a 322 
CUA (n=5) or cost-effectiveness analysis (CEA) (n=6) (Table 2). Table 2 demonstrates 323 
further how despite having the same aim to increase physical activity levels and same 324 
valuation technique, the way results are presented to the end-user are inconsistent. Young 325 
et al. (Young et al., 2012) performed two CEAs reporting on the ‘cost per incremental 326 
change in daily estimated energy expenditure’ and ‘cost per incremental change in minutes 327 
spent on moderate-to-vigorous activity’. Three other studies (Boehler et al., 2011; Elley et 328 
al., 2011; Iliffe et al., 2014) performed a different type of CEA reporting on ‘cost per 329 
participant achieving 150 minutes of moderate physical activity per week’. The most 330 
common way to present the result of the valuation analysis was as ‘cost per short-term 331 
quality-adjusted life year (QALY) gain’. Nevertheless, this was reported for just under half 332 
(n=7) of the economic evaluations: four trial-based (de Vries et al., 2016; Edwards et al., 333 
2013; Leung et al., 2012; Maddison et al., 2015) and three model-based (Anokye et al., 334 
2012; Campbell et al., 2015; Pavey et al., 2011) studies. All model-based studies 335 
conceptualised the long-term gain in QALY in the same way, in terms of the QALYs gained 336 
due to not developing coronary heart disease, stroke or type 2 diabetes, or experiencing 337 
premature mortality. Over et al.’s (2012) analysis differed slightly, as they also included 338 
colorectal and breast cancer. 339 
 340 
Rationale for the inclusion and exclusion of trial-derived QALYs varied considerably. Shaw 341 
et al. (Shaw et al., 2011) argued against the inclusion of trial-derived QALYs in their 342 
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analysis, explaining it would be unnecessarily restrictive since evidence already shows that 343 
physical activity is associated with a reduction in NCD and premature mortality, which in turn 344 
is associated with a much greater gain in QALYs than trial-derived QALYs. Three model-345 
based studies (Anokye et al., 2012; Campbell et al., 2015; Pavey et al., 2011) deemed it 346 
appropriate to incorporate both short-and long-term gain in QALYs. They conceptualised the 347 
short-term QALY gain as being a one-off gain in mental health, which they assumed would 348 
be achieved as a result of becoming physically active for at least 90 minutes per week. They 349 
assumed the one-off mental health benefit would last for just one year, which they claimed 350 
was a conservative assumption. Campbell et al. (2015) reported that their cost-effectiveness 351 
result was highly sensitive to the inclusion and exclusion of the one-off gain in mental health.  352 
 353 
Challenge 3: Identifying intersectoral costs and consequences 354 
The most commonly reported perspective was the health sector perspective (n=7) (Table 1 355 
and 2). Six of the eight studies from the UK were from this perspective. In 2014, the UK 356 
reference case was updated to recommend the public sector perspective when conducting 357 
economic evaluations of public health interventions (NICE, 2014). The multi-agency public 358 
sector perspective adopted by Edwards et al. (2013) reflects the start of this paradigm shift. 359 
Two more recent UK studies (Campbell et al., 2015; Iliffe et al., 2014) did not adopt a public 360 
sector perspective. Despite studies being conducted from the same perspective, the type of 361 
costs identified as relevant varied within and across countries and intervention type. This 362 
weakness was identified through the quality assessment (Item 4 on Appendix D [INSERT 363 
LINK TO ONLINE FILE A, B, C, D & E]), as five studies (Boehler et al., 2011; de Vries et al., 364 
2016; Maddison et al., 2015; Shaw et al., 2011; Young et al., 2012) did not relate their costs 365 
to a study perspective. More specifically, two studies did not report their perspective 366 
(Maddison et al., 2015; Shaw et al., 2011) and three included a narrower range of costs and 367 
consequences than would be expected for their stated perspective (Boehler et al., 2011; de 368 
Vries et al., 2016; Young et al., 2012). For example, two studies stated their study was from 369 
the societal perspective yet assessed only direct intervention costs and short-term 370 
healthcare savings (de Vries et al., 2016; Young et al., 2012), which were the same costs as 371 
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studies which stated taking a health sector perspective (Table 1 and 2). Weatherly et al. 372 
(2009) also found that many studies included only a narrow range of costs within their stated 373 
study perspectives.  374 
Figure 2. Cost categories identified across all 15 included studies 375 
Figure 2 shows that seven cost categories were identified across all 15 included studies. 376 
Like the findings in this review, Alayli-Goebbels et al. (2014) found the most common type of 377 
cost reported was the intervention costs, followed by healthcare costs. Participant out-of-378 
pocket expenses and productivity losses appeared in only a small proportion of studies in 379 
this review and Alayli-Goebbels et al.’s (2014) review. Although most studies looked at both 380 
the direct and indirect costs of the interventions, only Edwards et al. (2013) looked at the 381 
unintended productivity costs to the provider. More specifically, they examined whether the 382 
provider where the intervention was set (the leisure centre) experienced a loss in revenue, 383 
as a result of providing the intervention.  384 
Challenge 4: Incorporating equity 385 
The two former reviews found that authors did not routinely consider equity in their analysis 386 
(Alayli-Goebbels et al., 2014; Weatherly et al., 2009). Table 3 shows that all but one study 387 
(Shaw et al., 2011) included in the present review did consider equity. All but one study 388 
(Edwards et al., 2013) did this implicitly, conducting subgroup analyses of the cost-389 
effectiveness result (n=6) or targeting the intervention at a population deemed in need of 390 
intervention (n=8). Edwards et al. (2013) were the only authors to explicitly discuss equity 391 
and to consider socio-economic status in their equity analysis. They did this by asking 392 
participants from areas of different levels of deprivation about how much they would be 393 
willing to pay to participate in the intervention of interest; thus informing the reader about 394 
participants’ economic preferences. Notably this was an exploratory analysis and so the 395 
results were not incorporated in the CUA.  396 
Table 3. Types of equity considered 397 
Campbell et al. 2015 Pre-existing condition 
Pavey et al. 2011 Pre-existing condition 
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Subgroup analyses of 
cost-effectiveness 
result 
Anokye et al. 2011 Pre-existing condition 
Edwards et al. 2013;  
Murphy et al. 2012 
Medical diagnosis 
Referral reason 
Adherence to scheme 
Gender 
Inequalities 
Age group 
Over et al. 2012 Age group 
Anokye et al.2012 ; 
Anokye et al. 2014 
Age group 
Intervention targeted at 
equity group 
de Vries et al.2016 Frail older adults with mobility problems 
Leung et al.2012 Older adults  
Iliffe et al. 2014 Older adults  
Boehler et al. 2011 Older adults  
Maddison et al. 2015 People with ischaemic heart disease 
Elley et al. 2011 Females 
Young et al. 2012 Females 
Larsen et al. 2015 Latinas 
Willing to pay question Edwards et al. 2013;  
Murphy et al. 2012 
Socio-economic status (level of 
deprivation) 
 398 
Table 3 details the eight studies which targeted their intervention at a specific population 399 
group as well as the six studies that performed subgroup analyses of their cost-effectiveness 400 
result. Older adults was the most common equity subgroup targeted for intervention (Boehler 401 
et al., 2011; de Vries et al., 2016; Iliffe et al., 2014; Leung et al., 2012), followed by females 402 
(Elley et al., 2011; Young et al., 2012). The most common subgroup analyses were on pre-403 
existing condition/ medical diagnosis (Anokye et al., 2011; Campbell et al., 2015; Edwards et 404 
al., 2013; Pavey et al., 2011) and age group (Anokye et al., 2012; Edwards et al., 2013; 405 
Over et al., 2012). Edwards et al.(2013) carried out seven types of equity analyses, all other 406 
authors conducted just one type. Furthermore, no studies attempted alternative equity 407 
analyses, such as an equity constraint or equity weighing analysis (Cookson et al., 2017).  408 
New studies  409 
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The results of the rapid systematic scoping search are presented in Appendix B [INSERT 410 
LINK TO ONLINE FILE A, B, C, D & E]. In brief, four additional studies were identified as 411 
meeting the inclusion criteria of this review. Notably, one study (Gao et al., 2018) was an 412 
intervention targeting sedentary behaviour as an independent risk factor from physical 413 
activity. Furthermore, two studies (Gao et al., 2018; Harris et al., 2018) were both trial-and 414 
model-based economic evaluations, as the analysts had extrapolated their within-trial results 415 
a lifetime horizon. 416 
Discussion 417 
This review identified 15 economic evaluations of interventions that targeted physically 418 
inactive adults, and no economic evaluations of interventions that targeted sedentary adults 419 
(where sedentary behaviour was addressed an independent risk factor from physical 420 
activity). Like Abu-Omar et al’s (2017) review of reviews which focuses on the results of 421 
economic evaluations, this present review identified economic evaluations on a limited range 422 
of physical activity interventions (Abu-Omar et al., 2017). Studies came from just four high-423 
income countries, with over half (n=8) coming from the UK. This points to an important 424 
evidence gap in countries where economic evaluations are deemed appropriate. Examining 425 
a country’s traditional beliefs around personal responsibility, efficiency and equity can 426 
explain why countries such as France and Germany are low users of economic evaluations 427 
and can in part explain why no studies in this review originated from these countries (Torbica 428 
et al., 2018). Regardless of cultural and institutional differences, globally health economists 429 
agree economic evaluations of preventative interventions are expected to have an important 430 
impact on future healthcare decision-making (ISPOR, 2018). In order to answer upcoming 431 
complex public health challenges, researchers need to go beyond clinical effectiveness 432 
methods and use a multidisciplinary suite of methods (Rutter et al., 2017) which includes 433 
economic evaluation. A prerequisite for this is an understanding on how key methodological 434 
challenges can be addressed.  435 
Challenge 1: Attribution of effects 436 
Modelling exercises 437 
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All ten trial-based economic evaluations in this review had a short time horizon; meaning 438 
they did not attempt to extrapolate or model the long-term impact of the intervention which 439 
could be used to informer longer term investment decision making. Any future reduction in 440 
incidence of NCD and premature mortality, attributable to physical activity and sedentary 441 
behaviour interventions, is unlikely to manifest until decades after the intervention has taken 442 
place. Yet, evaluating these interventions over the wrong timeframe means these 443 
interventions may appear ineffective or markedly less effective; they are at risk of not being 444 
appropriately prioritised by policymakers (Rutter et al., 2017). Curative interventions that 445 
rescue people from very poor health to better health will continue to be favoured, even if 446 
they are less cost-effective overall. Alayli-Goebbels et al. (2014) had previously suggested 447 
modelling as a way to extend the time horizon of trial-based studies, yet none of the ten trial-448 
based studies in this review performed any modelling exercises. The challenges which can 449 
preclude extrapolation include the availability of data, and time and skills of the analyst 450 
(Squires et al., 2016). 451 
Cohort studies 452 
Campbell et al. (2015) and Anokye et al. (2012) were the only two studies in this review to 453 
identify additional evidence to link up their short- and long-term effect estimate. The three 454 
other model-based studies claimed there was insufficient evidence to verify the accuracy of 455 
their assumptions (Anokye et al., 2011; Over et al., 2012; Pavey et al., 2011). Notably, the 456 
cohort studies which Campbell et al.(2015) and Anokye et al.(2012) draw on were published 457 
several years prior to the publication of the three other model-based studies. This suggests 458 
that the methodological challenge of ‘attribution of effect’ may be more dependent upon the 459 
analysts’ time and skills as opposed to the availability of data.  460 
 461 
Challenge 2: Measuring and valuing outcomes 462 
Cost-effectiveness and cost-utility analyses 463 
This review found large inconsistencies in the types of outcomes measured and valued. 464 
There is no agreed classification system for physical activity outcomes(Abu-Omar et al., 465 
28 
 
2017) since the analysis of raw objective accelerometer data measuring objective physical 466 
activity levels is still in its infancy. Presenting a limited range of results can reduce the 467 
applicability of the study’s findings to other policymakers. Authors’ views also differed firstly 468 
on whether short-term QALYs should be included in the economic analysis, secondly on 469 
whether a short-term QALY gain represented a one-off gain in mental health or general 470 
functional health. Presently, within the economic literature the responsiveness of the EQ-5D-471 
3L to detect important differences in the severity of health is being challenged, and had led 472 
to the development of the EQ-5D-5L, which measures health on five levels as opposed to 473 
just three (Glick et al., 2014).  This review has shown that outcomes used in physical activity 474 
studies are diverse; therefore, there is a need for analysts to agree on a consistent outcome 475 
that best captures the objectives of a physical activity intervention.  476 
Cost-benefit and cost-consequence analyses 477 
No studies in this review performed a CBA and just two presented a CCA alongside their full 478 
economic evaluation. There is a lack of CBAs in other public health areas. Hill et al. (2017) 479 
and Alayli-Goebbels et al. (2014) identified a small proportion of studies (n=1 and n=8 480 
respectively) who reported conducting a CBA, but due to insufficient reporting gained limited 481 
insight into how these were performed such as how outcomes had been monetised (Alayli-482 
Goebbels et al., 2014; Hill et al., 2017). Likewise, four studies claimed to be CBAs in the 483 
review by Weatherly et al.(2009), but after further assessment were re-classified as CCAs 484 
(n=3) and a CEA (n=1). Although classified as a partial-economic evaluation, CCA is a 485 
useful alternative to CBA since all relevant costs and consequences can be presented to the 486 
reader in the form of an inventory, rather than simplified into a single outcome measure or 487 
index as is the case in CEA and CUA, respectively. If an outcome is deemed relevant to the 488 
reader, they can reanalyse the data quantified in the CCA. However, CCA puts more onus 489 
on decision makers than CBA or CUA, as it does not roll outcomes into a summary measure 490 
that can be compared to a decision rule. An example of a decision rule in the UK is: invest 491 
where the incremental cost-effectiveness ratio is less than £30,000 per QALY (NICE, 2014).  492 
 493 
Challenge 3: Identifying intersectoral costs and consequences 494 
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Inconsistent perspectives 495 
The three most common perspectives stated were the health system, payer and societal 496 
perspectives. These match the three most commonly reported perspectives in the broader 497 
field of economic evaluation (Husereau et al., 2013). Only Edwards et al. (2013) conducted 498 
their analysis from the public sector perspective, a perspective recently recommended in the 499 
UK reference case (NICE, 2014). That said, Edwards et al. (2013) did not incorporate 500 
participant costs in their CUA, only through an exploratory analysis. Only three studies 501 
considered the cost to the participant, which is not surprising since the health sector 502 
perspective was the most commonly stated perspective. Participant and voluntary sector 503 
costs are deemed important, but previously have not been routinely captured (Weatherly et 504 
al., 2009).  505 
It was found that even economic evaluations stated the same perspective did not always 506 
include the same costs and consequences. This is likely to be because there is a lack of 507 
standard definitions for the various perspective types (Husereau et al., 2013). Even where 508 
there are examples of standard definitions, such as those proposed by the Second US Panel 509 
on Cost-Effectiveness in Health and Medicine (Sanders et al., 2016), not all economists 510 
agree with their definitions, and furthermore the definitions may not be applicable to other 511 
countries since there are distinct features of each health system (Torbica et al., 2018). For 512 
instance, deciding what costs and consequences to capture within a societal perspective is a 513 
normative question, requiring the analyst to make social value judgements (Drummond et 514 
al., 2015). This is an important issue, since the exclusion of relevant consequences can lead 515 
to an underestimation of cost-effectiveness whilst the exclusion of relevant costs can lead to 516 
an overestimation of cost-effectiveness (Hill et al., 2017). 517 
Cost categories identified 518 
The cost categories identified in this review match the five cost categories (healthcare 519 
services, intervention costs, patient and family costs, lost productivity costs, future costs) 520 
identified as most relevant for inclusion in economic evaluations, by health economists who 521 
recently took part in a cross-Europe Delphi study (van Lier et al., 2017). This suggests 522 
analysts’ choice in costs in this review align with analysts in the more general field of 523 
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economic evaluation. It should be noted however that there was a difference in one of the 524 
categories, as family costs were not identified as a relevant cost category in the studies from 525 
this present review. Just two trial-based studies included absenteeism in their study; 526 
similarly only two of the model-based studies included it in their CCA. It continues to be 527 
debated in the literature as to whether absenteeism is an outcome of cost-offset, and thus 528 
whether it should be included in the numerator or denominator part of the incremental cost-529 
effectiveness fraction (Drummond et al., 2015).  530 
Challenge 4: Incorporating equity considerations 531 
Presenting results by subgroups 532 
Equity impact analysis can be as straightforward as presenting cost-effectiveness results by 533 
equity subgroups (Alayli-Goebbels et al., 2014; Hill et al., 2017; Weatherly et al., 2009). Six 534 
studies in this review presented an equity impact analysis (Anokye et al., 2012; Anokye et 535 
al., 2011; Campbell et al., 2015; Edwards et al., 2013; Over et al., 2012; Pavey et al., 2011). 536 
The most common subgroup analysed was individuals with pre-existing medical conditions, 537 
nevertheless this analysis was performed in just four studies (Anokye et al., 2011; Campbell 538 
et al., 2015; Edwards et al., 2013; Pavey et al., 2011). Furthermore, only one study 539 
(Edwards et al., 2013) conducted more than one type of equity subgroup analysis. These 540 
findings suggest analysts are not performing equity analyses in a comprehensive nor 541 
consistent manner. Weatherly et al. (2009) outlined socio-economic status as an important 542 
under-researched equity issue in economic evaluations, however only one study in this 543 
review researched socio-economic status by asking participants about their willingness to 544 
pay for an intervention component (Edwards et al., 2013). Incorporating equity into decisions 545 
on physical activity and sedentary behaviour interventions is especially important, since it is 546 
amongst the lower socioeconomic groups where physical inactivity is greatest (OECD, 547 
2015).  548 
New studies 549 
Overall, the four studies published since March 2017 did not change the narrative of this 550 
review since there remains a dearth of economic evaluations in the field of physical activity 551 
and sedentary behaviour. What the studies have demonstrated is that firstly, there is an 552 
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indication that health economic methods have begun to be applied to targeted sedentary 553 
behaviour interventions (Gao et al., 2018). Secondly, that it is feasible and informative to 554 
extrapolate beyond the trial (Gao et al., 2018; Harris et al., 2018). 555 
Strengths and limitations 556 
This is the first systematic review conducted since 2009 to review the methods used in 557 
economic evaluations of interventions targeted at physically inactive individuals, and the first 558 
systematic review to search for economic evaluations targeting sedentary behaviour as an 559 
independent risk factor from physical activity. This review included comprehensive literature 560 
searching and a rigorous methodology in line with the PRISMA guidelines (Moher et al., 561 
2009). Economic evaluations aim to inform resource allocation decisions (Drummond et al., 562 
2015). Previous reviews have demonstrated that key methodological challenges preclude 563 
economic evaluations in the field of public health from achieving this aim (Alayli-Goebbels et 564 
al., 2014; Weatherly et al., 2009). By focusing on physical activity and sedentary behaviour, 565 
this review has been able to not just provide an overview on whether or not the four key 566 
methodological challenges have been addressed in the last decade, but crucially explain in 567 
greater depth the methods performed in those few studies where progress has been made.  568 
More specifically, progress has been observed in the 14 studies which have considered 569 
equity in their analysis (Table 3) and the small proportion of studies where either: the long-570 
term model presented has been informed by robust epidemiological evidence (Anokye et al., 571 
2012; Campbell et al., 2015); all important and relevant costs and consequences have been 572 
outlined to the reader in the form of a cost-consequence analysis (Anokye et al., 2012; 573 
Pavey et al., 2011); and/or a multi-sector perspective has been selected (Edwards et al., 574 
2013). An output from the narrative synthesis of this review is a number of recommendations 575 
(as outlined in Table 4) explaining how analysts can continue to make progress towards 576 
addressing the four methodological challenges. Although, the comprehensive search 577 
strategy only goes upto March 2017, a rapid systematic scoping search is presented which 578 
highlights four new empirical studies. Two of these studies (Gao et al., 2018; Harris et al., 579 
2018) support the recommendations emerging from this review in terms of linking up the 580 
intermediate evidence with longer term policy relevant outcomes. 581 
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It was not within the scope of this research to review the methods used in population-level 582 
interventions such as national policies or media campaigns. It would therefore be useful for 583 
future reviews to explore how economic evaluations are being carried out within this area. In 584 
addition, this review focuses on the methods conducted in full economic evaluations and so 585 
there is scope to review the methods used in partial evaluations. Nevertheless, full economic 586 
evaluations are deemed more informative than partial evaluations, and so it would have 587 
been expected that analysts would conduct for instance, a CCA alongside their full economic 588 
evaluation, as was done in two studies (Anokye et al., 2014; Pavey et al., 2011) in this 589 
review.  590 
 591 
Recommendations  592 
Table  4  presents  a list of recommendations for researchers and users of economic 593 
evaluations from a variety of disciplines (health economics, public health, physical activity 594 
etc)  to refer to  when  designing, analysing and  appraising  economic evaluations of 595 
targeted physical activity and sedentary behaviour interventions.  596 
 597 
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Table 4. Recommendations for future economic evaluations 598 
Challenge 
 
Recommendation Explanation 
Challenge 1. 
Attribution of Effects 
Visual representations of disease 
pathways 
 
It is necessary for public health researchers to invest time in reviewing the existing 
evidence base and develop novel modelling skills. Best practice guidelines state well 
established published models are preferred to those developed specifically for a trial 
(Ramsey et al., 2015). If skill and time permits, analysts can draw on the structure of the 
published models (Anokye et al., 2012; Campbell et al., 2015) identified in this review 
and adapt them according to the local decision-making context. All five models in this 
review presented a visual depiction of the disease pathway for physical activity. Authors 
from non-economic disciplines could build on the disease pathways presented in the 
model-based studies in this review, in order to help policymakers and those designing 
interventions to consider the long-term costs and consequences of investing or 
disinvesting in physical activity interventions. The visual could be as simple as a logic 
model, a visual tool recommended for public health interventions (Moore et al., 2015).  
Long-term objective data derived 
from cohort studies 
 
Future investment and disinvestment decisions should be informed by economic 
evaluations which not only assess the short-term impact of interventions, but also 
impact on the medium- and long-term (Academy of Medical Sciences, 2016). As long-
34 
 
term RCTs of physical activity and sedentary behaviour interventions are likely to be 
impractical or unethical, evidence from non-experimental studies such as cohort studies 
could be drawn on to evidence the long-term impact of physical activity and sedentary 
behaviour interventions as done in two studies. In the hierarchy of evidence, cohort 
studies are recognised as being the next best alternative to RCTs (Murad et al., 2016). 
The popularity of wireless-enabled wearable activity monitors in high-income countries 
present researchers with an opportunity to conduct more cohort studies and collect 
objective data on behaviour change over a longer time period. 
Challenge 2. 
Measuring and valuing 
outcomes 
Quality of life measurement tools 
 
Future research should aim to understand whether a short-term gain in QALY 
represents a one-off benefit in mental health due to becoming physically active. The 
EQ-5D tool, is the most commonly used tool to measure QALYs but only captures the 
functional health of an individual. Future studies could use other recently developed 
quality of life tools such as the ICECAP-A (Al-Janabi et al., 2012; Al-Janabi et al., 2013; 
Flynn et al., 2015), which has been designed to capture capability in a broader sense, 
beyond functional health. Another solution is for analysts to agree on a tool which 
crosswalks between physical activity outcomes and a summary tool like the EQ-5D. 
There is currently a mapping database of studies that map the EQ-5D tool to other 
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outcomes measures (Dakin et al., 2018). No studies on the database have mapped a 
physical activity specific tool to the EQ-5D; future research should address this gap.  
Cost-consequence analysis 
 
There is a need for further methodological developments in the monetisation of effects 
in CBAs (Drummond et al., 2015; Sanders et al., 2016). In the meantime, it is deemed 
more appropriate to conduct a good quality CUA which may be of a narrower 
perspective, than a poor quality CBA which captures a broader perspective (Hill et al., 
2017; Weatherly et al., 2009). In order to report on multiple outcomes which extend 
beyond health, a CCA or impact inventory conducted alongside a full economic 
evaluation is recommended (NICE, 2014; Sanders et al., 2016). If the word limit in 
journals precludes authors from presenting a CCA in the main manuscript, they should 
present this information in the online supplementary material. 
Challenge 3. 
Identifying 
intersectoral costs 
and consequences 
 
Multi-sector perspective 
 
Three studies in this review omitted costs which would typically be deemed relevant to 
their stated perspective, and two studies did not report their perspective. It is imperative 
for analysts to describe and justify the costs and consequences which they have 
deemed relevant for their chosen perspectives (Husereau et al., 2013). Inevitably 
different assumptions on what costs and consequences are included in the analysis 
leads to different results (Sanders et al., 2016). Furthermore, future studies should aim 
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to present at least two types of perspectives and conduct a CCA or impact inventory 
alongside their CUA or CEA in order to present the various relevant costs and 
consequences to the various relevant sectors (Alayli-Goebbels et al., 2014; Sanders et 
al., 2016; Weatherly et al., 2009). A multi-sector perspective where costs and 
consequences are presented in their disaggregated form (i.e. in a CCA) for each sector 
is preferred over stating a societal perspective (Drummond et al., 2015; Hill et al., 2017).  
Systems thinking approach 
 
Absenteeism was the only non-health effect identified in the two CCAs in this review 
(Anokye et al., 2012; Pavey et al., 2011). During the design stage of future economic 
evaluations analysts could conduct multi-stakeholder and expert consultations to map 
out which costs and consequences are deemed relevant to physical activity and 
sedentary behaviour interventions (Squires et al., 2016). A systems thinking approach 
(Rutter et al., 2017; Squires et al., 2016) is recommended to ensure interventions’ 
indirect and unintended costs and consequences on the whole system are considered, 
not just those experienced by the health sector or payer. Two recently published 
frameworks can help analysts apply a systems approach (Cylus et al., 2016; Squires et 
al., 2016).  
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Challenge 4. 
Incorporating equity 
 
Equity impact analysis 
 
Analysts should present costs and consequences explicitly in their disaggregated form 
for various equity groups, so policymakers can start to build a better picture on which 
population groups gain and lose from a specific decision (Hill et al., 2017). From here, 
analysts can conduct an equity impact analysis. This type of analysis is deemed easier 
than conducting equity constraint or equity weighting analysis (Hill et al., 2017). The 
equity effectiveness loop framework (Welch et al., 2008) and PROGRESS-Plus 
framework (O'Neill et al., 2014) are recommended to help analysts consider, in a 
structured way, which equity factors may be relevant to their study (Alayli-Goebbels et 
al., 2014; Welch et al., 2017).   
Participant’s preferences 
 
Other types of equity-related analyses not identified in this review, but which future 
studies could investigate, include the public’s perspective on trading off efficiency with 
equity (in public services) (Weatherly et al., 2009). It is also recommended that future 
studies, specifically trial-based studies, capture economic information on time, travel 
and out-of-pocket expenses incurred by the participant. The APEASE criteria by Michie 
et al. (2014) could also help analysts to consider the acceptability and affordability of an 
intervention to various stakeholders. Inevitably, these two issues will contribute to the 
success of interventions aiming to change behaviour (Michie et al., 2014). 
599 
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 600 
Conclusions 601 
A focus on the key methodological challenges in economic evaluations is important, as they 602 
can impact on the derived cost-effectiveness result, which ultimately can impact on a 603 
policymaker’s resource allocation decision. As economic evaluation is a rapidly developing 604 
field (Drummond et al., 2015) this systematic review has provided an important update on 605 
the most recent methods used in targeted physical activity interventions. The review has 606 
also highlighted there is a scarcity of economic evaluations for targeted sedentary behaviour 607 
interventions. Importantly, this review makes it explicit to policymakers and researchers from 608 
the varied disciplines in which physical activity and sedentary behaviour falls under, that 609 
there are still key methodological challenges that need further attention. This review has 610 
highlighted that methodological choices vary widely not just between countries but also 611 
within them. Ultimately, these analyst-based choices affect the results presented and 612 
subsequent resource allocation decisions made. A recent consensus statement has called 613 
for collaboration across the disciplines to develop guidance specific to the context of 614 
economic evaluations of physical activity interventions (Davis et al., 2014). To date, no 615 
guidelines have been developed to address this need. The examples of methodological 616 
development identified from the studies in this review and the resulting review 617 
recommendations can be used to inform future guidelines and their supplementary 618 
materials.   619 
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